News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
82,310 Results
Type
Article (9597)
Company Profile (51)
Press Release (72662)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (21655)
Career Advice (107)
Deals (3042)
Drug Delivery (10)
Drug Development (12167)
Employer Resources (14)
FDA (1756)
Job Trends (2211)
News (37573)
Policy (3139)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (649)
Accelerated approval (9)
Adcomms (5)
Allergies (10)
Alliances (6909)
ALS (39)
Alzheimer's disease (313)
Antibody-drug conjugate (ADC) (19)
Approvals (1801)
Artificial intelligence (74)
Autoimmune disease (13)
Automation (5)
Bankruptcy (15)
Best Places to Work (2105)
BIOSECURE Act (3)
Biosimilars (9)
Biotechnology (44)
Bladder cancer (21)
Brain cancer (20)
Breast cancer (64)
Cancer (677)
Cardiovascular disease (92)
Career advice (93)
Career pathing (2)
CAR-T (61)
Celiac Disease (1)
Cell therapy (184)
Clinical research (9813)
Collaboration (337)
Compensation (177)
Complete response letters (15)
COVID-19 (379)
CRISPR (55)
C-suite (130)
Cystic fibrosis (90)
Data (1216)
Denatured (1)
Depression (9)
Diabetes (60)
Diagnostics (1538)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (50)
Drug pricing (4)
Duchenne muscular dystrophy (111)
Earnings (7063)
Editorial (8)
Employer branding (3)
Employer resources (13)
Events (12501)
Executive appointments (118)
FDA (2267)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (216)
Gene editing (133)
Generative AI (4)
Gene therapy (319)
GLP-1 (99)
Government (491)
Grass and pollen (1)
Guidances (56)
Healthcare (2279)
HIV (10)
Huntington's disease (21)
IgA nephropathy (15)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (14)
Infectious disease (405)
Inflammatory bowel disease (32)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (26)
Interviews (14)
IPO (1573)
IRA (1)
Job creations (265)
Job search strategy (89)
JPM (7)
Kidney cancer (1)
Labor market (3)
Layoffs (59)
Legal (391)
Liver cancer (10)
Longevity (2)
Lung cancer (79)
Lymphoma (85)
Machine learning (6)
Management (1)
Manufacturing (103)
MASH (6)
Medical device (289)
Medtech (289)
Mergers & acquisitions (1597)
Metabolic disorders (164)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (73)
Neuropsychiatric disorders (6)
Neuroscience (548)
NextGen: Class of 2026 (732)
Non-profit (674)
Now hiring (5)
Obesity (88)
Opinion (49)
Ovarian cancer (10)
Pain (13)
Pancreatic cancer (27)
Parkinson's disease (64)
Partnered (2)
Patents (46)
Patient recruitment (65)
Peanut (1)
People (7250)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (3775)
Phase 2 (4480)
Phase 3 (3154)
Pipeline (841)
Policy (19)
Postmarket research (212)
Preclinical (1703)
Press Release (18)
Prostate cancer (25)
Psychedelics (3)
Radiopharmaceuticals (17)
Rare diseases (431)
Real estate (497)
Recruiting (3)
Regulatory (2961)
Reports (9)
Research institute (780)
Resumes & cover letters (11)
Rett syndrome (26)
RNA editing (11)
RSV (3)
Schizophrenia (12)
Series A (36)
Series B (34)
Service/supplier (1)
Sickle cell disease (46)
Special edition (3)
Spinal muscular atrophy (139)
Sponsored (6)
Startups (619)
Supply chain (6)
Tariffs (2)
The Weekly (6)
Vaccines (91)
Venture capital (11)
Weight loss (31)
Women's health (9)
Date
Last 7 days (93)
Last 30 days (326)
Last 365 days (4581)
2026 (459)
2025 (4659)
2024 (5460)
2023 (5838)
2022 (7858)
2021 (8215)
2020 (6699)
2019 (5454)
2018 (4075)
2017 (4190)
2016 (3759)
2015 (4318)
2014 (3029)
2013 (2412)
2012 (2183)
2011 (2162)
2010 (1903)
Location
Africa (95)
Alabama (4)
Alaska (2)
Arizona (16)
Arkansas (1)
Asia (3899)
Australia (766)
California (1819)
Canada (320)
China (102)
Colorado (67)
Connecticut (53)
Delaware (23)
Europe (10866)
Florida (173)
Georgia (16)
Hawaii (1)
Idaho (4)
Illinois (57)
India (4)
Indiana (166)
Iowa (3)
Japan (86)
Kansas (6)
Kentucky (4)
Louisiana (6)
Maine (3)
Maryland (179)
Massachusetts (1824)
Michigan (74)
Minnesota (21)
Missouri (4)
Montana (2)
Nebraska (4)
Nevada (14)
New Hampshire (3)
New Jersey (290)
New Mexico (4)
New York (456)
North Carolina (238)
North Dakota (5)
Northern California (955)
Ohio (53)
Oklahoma (1)
Oregon (4)
Pennsylvania (331)
Puerto Rico (2)
Rhode Island (7)
South America (121)
South Carolina (3)
Southern California (659)
Tennessee (5)
Texas (246)
United States (6327)
Utah (140)
Virginia (55)
Washington D.C. (10)
Washington State (160)
Wisconsin (12)
82,310 Results for "ambry genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
February 2, 2026
·
6 min read
Press Releases
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
February 5, 2026
·
7 min read
Press Releases
Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
October 20, 2025
·
6 min read
Press Releases
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
October 2, 2025
·
8 min read
Press Releases
Ambry Genetics’ CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing
June 25, 2025
·
7 min read
Press Releases
New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis
May 27, 2025
·
7 min read
Biotech Beach
Ambry Genetics Announces a Collaboration with Tempus to Advance Paired Germline and Somatic Testing Services for Medical Oncologists
Ambry Genetics announced that they have entered into a strategic collaboration to offer best-in-class, comprehensive, germline and somatic testing services.
March 12, 2024
·
3 min read
Biotech Bay
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced their companies’ selection by the University of California, Irvine and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program to better understand the underlying biology of rare diseases.
May 15, 2024
·
6 min read
Business
Ambry Genetics Announces New Hereditary Cancer Test Menu at NSGC Annual Conference
September 17, 2024
·
4 min read
Biotech Beach
Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., unveiled at the American Society of Human Genetics annual meeting results of a study published in JAMA Oncology that assessed the cumulative impact of paired DNA and RNA testing on detecting disease-causing germline genetic variants and resolution of variants of uncertain significance.
November 4, 2023
·
4 min read
1 of 8,231
Next
